U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,061 records

Showing results for "consideration".

  1. Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. | PSNet

    psnet.ahrq.gov/issue/benzocaine-sprays-marketed-under-different-names-including-hurricaine-topex-and-cetacaine
    December 02, 2015 - Government Resource Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. Citation Text: Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. Food and Drug Administration; FDA; CDER; Center for Drug Evaluati…

  2. Intrahospital patient transport: checklists, adverse events, and other considerations for the anesthesia professional. | PSNet

    psnet.ahrq.gov/issue/intrahospital-patient-transport-checklists-adverse-events-and-other-considerations-anesthesia
    April 24, 2019 - Newspaper/Magazine Article Intrahospital patient transport: checklists, adverse events, and other considerations for the anesthesia professional. Citation Text: Andrew C, Fitzsimons M. Intrahospital patient transport: checklists, adverse events, and other considerations for the anesthesi…

  3. Quality and Safety Considerations in Intensity Modulated Radiation Therapy: An ASTRO Safety White Paper Update. | PSNet

    psnet.ahrq.gov/issue/quality-and-safety-considerations-intensity-modulated-radiation-therapy-astro-safety-white
    October 30, 2024 - Organizational Policy/Guidelines Quality and Safety Considerations in Intensity Modulated Radiation Therapy: An ASTRO Safety White Paper Update. Citation Text: Moran JM, Bazan JG, Dawes SL, et al. Quality and Safety Considerations in Intensity Modulated Radiation Therapy: An ASTRO Safety…

  4. Intravenous admixture preparation considerations, Parts 9-A and 9-B: error prevention in intravenous admixture preparation. | PSNet

    psnet.ahrq.gov/issue/intravenous-admixture-preparation-considerations-parts-9-and-9-b-error-prevention-intravenous
    December 22, 2021 - Special or Theme Issue Intravenous admixture preparation considerations, Parts 9-A and 9-B: error prevention in intravenous admixture preparation. Citation Text: Intravenous admixture preparation considerations, Parts 9-A and 9-B: error prevention in intravenous admixture preparation. Al…

  5. COVID-19: Team and Human Factors to Improve Safety | PSNet

    psnet.ahrq.gov/primer/covid-19-team-and-human-factors-improve-safety
    September 15, 2024 - Consideration of the humanness of care in the broader context of patient safety can raise awareness of … organizational resilience, patient safety, and staff retention during COVID-19 requires a holistic consideration

  6. Root Cause Analysis Gone Wrong | PSNet

    psnet.ahrq.gov/web-mm/root-cause-analysis-gone-wrong
    August 28, 2024 - is based on the Organizational Accident Causation Model ( Figure ).( 12 ) Such frameworks facilitate consideration … lead to the ultimate goal (elimination of 10 times drug errors in this case).( 21 ) Another important consideration

  7. Sepsis Resulting from Delays in Treatment and Miscommunication among Specialists | PSNet

    psnet.ahrq.gov/web-mm/sepsis-resulting-delays-treatment-and-miscommunication-among-specialists
    February 26, 2025 - discussed at this colorectal surgery visit; the patient was “urgently” referred to a urologist for consideration … Individualized management decisions require careful consideration of the etiology and severity of the

  8. Key considerations in ensuring a safe regional telehealth care model: a systematic review. | PSNet

    psnet.ahrq.gov/issue/key-considerations-ensuring-safe-regional-telehealth-care-model-systematic-review
    August 25, 2021 - Review Key considerations in ensuring a safe regional telehealth care model: a systematic review. Citation Text: Haveland S, Islam S. Key considerations in ensuring a safe regional telehealth care model: a systematic review. Telemed J E Health. 2022;28(5):602-612. doi:10.1089/tmj.2020.05…

  9. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33598/psn-pdf
    June 15, 2024 - The other consideration is acknowledging the tension between fall prevention and other goals of a patient's

  10. Identifying errors and safety considerations in patients undergoing thrombolysis for acute ischemic stroke. | PSNet

    psnet.ahrq.gov/issue/identifying-errors-and-safety-considerations-patients-undergoing-thrombolysis-acute-ischemic
    February 09, 2022 - Study Identifying errors and safety considerations in patients undergoing thrombolysis for acute ischemic stroke. Citation Text: Dancsecs KA, Nestor M, Bailey A, et al. Identifying errors and safety considerations in patients undergoing thrombolysis for acute ischemic stroke. Am J Emerg …

  11. Society for Maternal-Fetal Medicine Special Statement: telemedicine in obstetrics-quality and safety considerations. | PSNet

    psnet.ahrq.gov/issue/society-maternal-fetal-medicine-special-statement-telemedicine-obstetrics-quality-and-safety
    August 10, 2022 - Organizational Policy/Guidelines Society for Maternal-Fetal Medicine Special Statement: telemedicine in obstetrics-quality and safety considerations. Citation Text: Healy A, Davidson C, Allbert J, et al. Society for Maternal-Fetal Medicine Special Statement: telemedicine in obstetrics-qu…

  12. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33616/psn-pdf
    August 01, 2005 - Legislative mandates specifying minimum nurse staffing ratios have been enacted in California and are under consideration

  13. Accidental exposures to fentanyl patches continue to be deadly to children. | PSNet

    psnet.ahrq.gov/issue/fentanyl-patch-can-be-deadly-children
    January 13, 2021 - Fact Sheet/FAQs Accidental exposures to fentanyl patches continue to be deadly to children. Citation Text: Accidental exposures to fentanyl patches continue to be deadly to children. Rockville, MD: US Food and Drug Administration; 2021. Copy Citation Save Save …

  14. "Do no harm": promoting anti-racist policing in pediatric emergency departments through 20 practice change considerations. | PSNet

    psnet.ahrq.gov/issue/do-no-harm-promoting-anti-racist-policing-pediatric-emergency-departments-through-20-practice
    August 12, 2020 - Commentary "Do no harm": promoting anti-racist policing in pediatric emergency departments through 20 practice change considerations. Citation Text: Wells JM, Walker VP. "Do no harm": promoting anti-racist policing in pediatric emergency departments through 20 practice change considerati…

  15. The evolution of the Anesthesia Patient Safety Movement in America: lessons learned and considerations to promote further improvement in patient safety. | PSNet

    psnet.ahrq.gov/issue/evolution-anesthesia-patient-safety-movement-america-lessons-learned-and-considerations
    September 14, 2022 - Commentary The evolution of the Anesthesia Patient Safety Movement in America: lessons learned and considerations to promote further improvement in patient safety. Citation Text: Warner MA, Warner ME. The evolution of the Anesthesia Patient Safety Movement in America: lessons learned and…

  16. Spotlight (pdf file)

    psnet.ahrq.gov/sites/default/files/2022-01/final_spotlight_stacked_opioid_administration_01.03.2022.pdf
    January 01, 2022 - • Taking these factors into consideration, if a subsequent opioid dose is administered prior to the … of patient-reported inadequate pain relief and repeated opioid dose administration without careful consideration

  17. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/45034/psn-pdf
    February 25, 2019 - Future directions for diagnostic decision support. February 25, 2019 Carr S. ImproveDx. April 2016;3:1-3. https://psnet.ahrq.gov/issue/future-directions-diagnostic-decision-support Clinical decision support systems are tools being used to augment clinical reasoning and diagnostic accuracy. This newsletter article …

  18. Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry. | PSNet

    psnet.ahrq.gov/issue/best-practices-developing-proprietary-names-human-prescription-drug-products-guidance
    January 13, 2021 - Book/Report Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry. Citation Text: Best Practices in Developing Proprietary Names for Human Prescription Drug Products Guidance for Industry. Rockville, MD: US Department of Health and Huma…

  19. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49829/psn-pdf
    May 01, 2018 - is based on the Organizational Accident Causation Model (Figure).(12) Such frameworks facilitate consideration … lead to the ultimate goal (elimination of 10 times drug errors in this case).(21) Another important consideration

  20. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49664/psn-pdf
    January 01, 2013 - the dynamic nature of most handoff situations, a defense-in-depth strategy might also be worthy of consideration … Standardization should take into consideration: preparation for handover, technology transfer, information
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites